Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Regeneron CEO Schleifer bags massive $135M payday after 2020 pandemic wins
Fierce Pharma
Mon, 04/26/21 - 11:10 am
Regeneron
Len Schleifer
Pharma CEOs
executive pay
Regeneron looks to inject another $330M into long-running manufacturing expansion plan: report
Fierce Pharma
Sun, 04/25/21 - 01:49 pm
Regeneron
drug manufacturing
New York
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Motley Fool
Wed, 04/21/21 - 10:37 am
Regeneron
antibodies
COVID-19
Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81%
Endpoints
Mon, 04/12/21 - 11:09 am
Regeneron
monoclonal antibodies
NIH
COVID-19
Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data
Fierce Pharma
Fri, 04/2/21 - 10:55 am
Regeneron
FDA
Eylea
diabetic retinopathy
NIH
Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?
Motley Fool
Wed, 03/31/21 - 10:37 am
Regeneron
vaccines
antibodies
COVID-19
Regeneron used Cuomo connections to get R&D chief Yancopoulos early COVID testing: NYT
Fierce Pharma
Fri, 03/26/21 - 10:49 am
Regeneron
George Yancopoulos
Andrew Cuomo
COVID-19
Regeneron and Roche's antibody cocktail shown helping in COVID-19 cases
Reuters
Tue, 03/23/21 - 10:42 am
Regeneron
Roche
clincial trials
COVID-19
Sanofi, Regeneron’s Libtayo improves survival in cervical cancer patients
Pharma Times
Mon, 03/15/21 - 10:48 am
Sanofi
Regeneron
Libtayo
cervical cancer
clinical trials
Libtayo scores second OK in two weeks, this time for front-line NSCLC. Can it take on Keytruda?
Endpoints
Mon, 02/22/21 - 11:51 pm
Regeneron
Libtayo
non-small cell lung cancer
Merck
Keytruda
Novartis’s canakinumab cancer test approaches
EP Vantage
Fri, 02/12/21 - 11:06 am
Novartis
Regeneron
canakinumab
cancer
non-small cell lung cancer
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Fri, 02/12/21 - 10:48 am
Amgen
patents
Sanofi
Regeneron
Praluent
Repatha
Merck
Regeneron's Evkeeza, carrying big price tag, wins FDA approval in ultra-rare cholesterol disease
Fierce Pharma
Thu, 02/11/21 - 10:36 pm
Regeneron
Evkeeza
Homozygous Familial Hypercholesterolemia
FDA
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
Yahoo/Benzinga
Wed, 02/10/21 - 10:32 am
Sanofi
Regeneron
Libtayo
FDA
advanced basal cell carcinoma
skin cancer
Regeneron has a winner in Dupixent and big sales hopes. So why are so few patients taking it?
Endpoints
Mon, 02/8/21 - 10:25 am
Dupixent
Regeneron
Sanofi
eczema
Mark Your Calendar For February PDUFA Dates
Yahoo/Benzinga
Sun, 01/31/21 - 10:18 pm
FDA
Adamas Pharmaceuticals
Gocovri
Mallinckrodt
StrataGraft
Regeneron
evinacumab
Sanofi
Sarepta
TG Therapeutics
Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly's does not - study
Reuters
Wed, 01/27/21 - 08:06 pm
Regeneron
Eli Lilly
antibodies
COVID-19
Go or no go? Oncology decisions ahead for the FDA
EP Vantage
Wed, 01/27/21 - 11:55 am
FDA
cancer
oncology
Bristol-Myers Squibb
TG Therapeutics
Mallinckrodt
Sanofi
Regeneron
Sarepta Therapeutics
GSK
Oncopeptide
Regeneron says monoclonal antibodies prevent Covid-19 in study
Stat
Tue, 01/26/21 - 11:34 am
Regeneron
antibodies
COVID-19
Roche eyes FDA filing after bispecific matches Eylea again
Fierce Biotech
Mon, 01/25/21 - 10:44 am
Roche
bispecifics
Regeneron
Eylea
clinical trials
faricimab
wet age-related macular degeneration
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »